Codiak Biosciences Competitors and Similar CompaniesClear all

Codiak Biosciences's competitors and similar companies include AstraZeneca and Evox Therapeutics.

	Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.	AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.	Evox Therapeutics Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies.
Founding Date	Founding Date 2015	Founding Date 1999	Founding Date 2016
Type	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech therapy	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare bioengineering biotech drug development genetics nanotech pharma therapy
Locations	Locations Cambridge, US HQ	Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more	Locations Oxford, GB HQ
Employees	Employees 992% decrease	Employees 94,300	Employees 452% decrease
Valuation ($)	Valuation ($) 2.8 m	Valuation ($) 2.7 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $22.9m (FY, 2021)	Revenue (est.) $58.7b (FY, 2025)	Revenue (est.) N/A
Net income	Net income ($37.2m) (FY, 2021)	Net income $10.2b (FY, 2025)	Net income N/A
Funding
Total funding raised	Total funding raised $ 168.5m	Total funding raised $ 1b	Total funding raised $ 158.6m